Boehringer Ingelheim Pharmaceuticals, Inc.
$148.9M 216,716 recipients
Compare payment profiles
CMS Open Payments · Program Year 2024
Stryker Corporation
Stryker Corporation reported $140,997,648.23 across General Payments, Research, and Ownership to 168,381 physicians and teaching hospitals across 169,396 transactions.
- $141.0M Top 1% payer
- All-tracks total
- 169,396 Top 1% volume
- Transactions
- 168,381 Top 10% reach
- Recipients
- +$14.6M
- General Payments vs PY2023
Stryker Corporation reported $140,997,648.23 across all CMS Open Payments tracks (General + Research + Ownership) to 168,381 physicians and teaching hospitals in Program Year 2024 - ranking #18 of 1,925 reporting manufacturers (1.0% of the all-tracks industry total); General Payments alone were $134,704,914.55, averaging $837.37 per recipient.
How Stryker Corporation's $141.0M all-tracks total breaks down
Stryker Corporation's payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
A
100/100
Total payments
A
100/100
Transaction volume
A
100/100
Physician reach
A
100/100
Payment type diversity
A
100/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer stryker-corporation Stryker Corporation
$141.0M · #18/1,925 · 1.0% industry · PY2024
- TOT $141.0M
- RANK #18
- SHARE 1.0%
- TXN 169,396
- RCP 168,381
- CAT 11
- GEN $134.7M
- ΔGEN +$14.6M
- TOP1 2.8%
- PY 2024
Volume peers
Nearest volume peer: Boehringer Ingelheim Pharmaceuticals, Inc. ($148.9M)
Stryker Corporation sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Stryker Corporation's CMS-reported General Payments increased by $14.6M (+12.1%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: STRYKER CORPORATIONPY2023: STRYKER CORPORATIONPY2024: Stryker Corporation. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $120,144,263.80
- PY2024
- $134,704,914.55
What the Data Shows for Stryker Corporation
The all-tracks total above combines three CMS reporting categories - General Payments, Research Payments, and Ownership/Investment interests - not one undifferentiated figure. For Stryker Corporation, that total blends General Payments (day-to-day consulting, meals, travel and speaking fees, shown separately above) with Research and Ownership/Investment interest records, each governed by its own CMS reporting rules. CMS publishes each Program Year's data roughly 12 months after the reporting period ends, so this reflects the most recently released cycle; see our methodology for how the tracks are standardized and compared across companies.
1,112 transactions worth $77.9M make "Royalty or License" the top general-payment category in the 11-category breakdown below, 57.8% of General Payments (see our methodology for how research and ownership payments are reported separately).
General Payment Breakdown by Type
Across 11 types of general payments, Stryker Corporation's largest category was "Royalty or License" at $77.9M - 57.8% of General Payments.
Stryker Corporation reports 11 general-payment categories - the top three are Royalty or License (57.8%), Consulting Fee (19.6%), and Travel and Lodging (5.9%). The remaining 8 categories make up 16.8% of this company's reported general-payment total. That multi-category mix is the kind of profile single-category reporters cannot show.
Category breadth matters here: Stryker Corporation files across 11 named CMS general-payment types in Program Year 2024, versus manufacturers that report a single dominant category. The chart and table below enumerate every type with an amount above zero for this company.
How Stryker Corporation divides its payments
Ranked by total dollars reported per category
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Royalty or License | $77.9M | 1,112 | 57.8% |
| Consulting Fee | $26.3M | 6,995 | 19.6% |
| Travel and Lodging | $7.9M | 24,631 | 5.9% |
| Food and Beverage | $7.6M | 131,277 | 5.6% |
| Acquisitions | $6.9M | 17 | 5.1% |
| Long-Term Medical Supply or Device Loan | $4.0M | 2,516 | 3.0% |
| Debt Forgiveness | $2.0M | 719 | 1.5% |
| Space Rental or Facility Fees | $1.7M | 385 | 1.3% |
| Grant | $206.5K | 30 | 0.2% |
| Education | $179.8K | 698 | 0.1% |
| Compensation for Services Other Than Consulting | $140.00 | 1 | 0.0% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $13,661,684.74 (10.1%) of $134,704,914.55 in this company's General Payments records across 33,802 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Stryker Corporation
The five named recipients with the highest reported General Payments from this company
- 1
John Carbone
$3,796,061.86 across 11 reported transactions
- 2
Indiana University Health
$3,531,834.19 across 15 reported transactions
- 3
Steven Haddad
$2,224,081.35 across 189 reported transactions
- 4
Massachusetts General Hospital
$2,156,082.12 across 8 reported transactions
- 5
Thomas Coon
$1,953,625.22 across 5 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
Stryker Corporation ranks #18 of 1,925 by total payments (top 1% by spend) but spreads that money notably more broadly than its spend rank alone would suggest -- #1,741 of 1,838 by HHI (bottom 5% least concentrated), a wider distribution than most similarly sized payers.
View all 12 companies in this HHI neighborhood as a list
- Merck Sharp & Dohme LLC : $23.2M total payments, HHI 69
- Life Molecular Imaging Ltd : $8.0K total payments, HHI 68
- Ironwood Pharmaceuticals, Inc : $659.4K total payments, HHI 68
- Novus Surgical Consultants : $122.1K total payments, HHI 68
- UCB, Inc. : $18.4M total payments, HHI 68
- Linus Health, Inc. : $4.8K total payments, HHI 67
- Stryker Corporation (this company) : $134.7M total payments, HHI 67
- Supreme Orthopedic Systems, LLC : $90.9K total payments, HHI 66
- VivaQuant Inc, dba Rhythm Express : $4.5K total payments, HHI 64
- Colgate Oral Pharmaceuticals, Inc. : $238.5K total payments, HHI 64
- Meditrina : $27.7K total payments, HHI 62
- Integra LifeSciences Corporation : $3.0M total payments, HHI 61
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Stryker Corporation's, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Stryker Corporation.
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Stryker Corporation.
Showing 6 of 1,924 companies with CMS-reported payment data.
AstraZeneca UK Limited
$124.7M 2,367 recipients
Compare payment profiles
Regeneron Pharmaceuticals, Inc.
$123.5M 5,932 recipients
Compare payment profiles
Sanofi US Services Inc.
$114.0M 478 recipients
Compare payment profiles
Edge Endo LLC
$113.4M 40 recipients
Compare payment profiles
Trimed, Inc.
$111.0M 2,318 recipients
Compare payment profiles
Put this to use
Stryker Corporation ranks #18 of 1,925 by all-tracks total payments, led by "Royalty or License".
- See where Stryker Corporation sits among every top spender on the full leaderboard. Top 100 by total payments
- Compare "Royalty or License" spend across every manufacturer, not just Stryker Corporation. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.